Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Relypsa announces topline data from second part of patiromer phase III trial

Oct. 11, 2013

FDA accepts filing of Zerenex NDA

Oct. 9, 2013

TRK-390 as a novel and highly selective phosphate binder

Oct. 8, 2013

AM-Pharma begins phase I trial with new recombinant AP product

Sep. 26, 2013

CHMP issues positive opinion for PSD-502 in premature ejaculation

Sep. 25, 2013

Relypsa reports data on part A of its phase III patiromer trial

Sep. 16, 2013

ChemoCentryx reports interim data for CCX-140 in patients with diabetic nephropathy

Sep. 13, 2013

Genkyotex obtains IND approval for phase II study of GKT-137831

Sep. 9, 2013

Rockwell Medical reports findings from CRUISE-2 study of SFP

Sep. 5, 2013

Swissmedic opposes approval of Vitaros

Sep. 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...